Congestive heart failure (CHF) is a debilitating condition that afflicts tens of millions of
people worldwide and is responsible for more deaths each year than all cancers combined …

Addition of Impella on top of veno-arterial extracorporeal membrane oxygenation has
gained wide interest as it might portend improved outcomes in patients with cardiogenic …

Objectives: We studied the effects of LV unloading by the Impella on coronary
hemodynamics by simultaneously measuring intracoronary pressure and flow and the …

Background Delivering therapeutic materials, like stem cells or gene vectors, to the
myocardium is difficult in the setting of ischemic heart failure because of decreased coronary …

Background Percutaneous assist devices may be used as a bridge to recovery in patients
with acute myocardial infarction complicated by cardiogenic shock (CS-AMI). Aim To test the …

Patients in a variety of cardiovascular disease states may benefit from temporary
percutaneous cardiac support, including those in acute decompensated heart failure …

Objectives: We studied online left ventricular (LV) dynamic effects of mechanical LV
unloading directly after percutaneous coronary intervention (PCI). Background: Limited …

Some patients in need of hemodynamic support do not respond to intra‐aortic balloon pump
(IABP) therapy. Hemodynamic stability can then be obtained by a more potent cardiac assist …

Background The new heart allocation policy places veno‐arterial extracorporeal membrane
oxygenation (VA‐ECMO)‐supported heart transplant (HT) candidates at the highest priority …

Despite advances in pharmacological treatments aimed at neurohormonal blockade for
heart failure in the setting of left ventricular pump dysfunction, there is still a growing number …